Useful resources |
Aminopyridines for symptomatic treatment in multiple sclerosis (Cochrane Review) ABSTRACT Background: The potassium channel blockers 4-aminopyridine (AP) and 3,4-diaminopyridine (DAP) increase nerve conduction in demyelinated nerve fibers, and have been proposed as a symptomatic therapy for people with multiple sclerosis (MS). |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |